Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing Type
4
Filing Date
4/9/2023
Updated
4/10/23, 10:29 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership